275 related articles for article (PubMed ID: 17022858)
1. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
[TBL] [Abstract][Full Text] [Related]
2. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
[TBL] [Abstract][Full Text] [Related]
4. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
Welcker JT; Nawroth F; Bilger W
Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
[TBL] [Abstract][Full Text] [Related]
6. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
[TBL] [Abstract][Full Text] [Related]
7. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
[TBL] [Abstract][Full Text] [Related]
8. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
[TBL] [Abstract][Full Text] [Related]
10. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women.
Kaufmann R; Dunn R; Vaughn T; Hughes G; O'Brien F; Hemsey G; Thomson B; O'Dea LS
Clin Endocrinol (Oxf); 2007 Oct; 67(4):563-9. PubMed ID: 17692110
[TBL] [Abstract][Full Text] [Related]
12. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
15. Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
Bühler K
Ther Clin Risk Manag; 2015; 11():995-1001. PubMed ID: 26170678
[TBL] [Abstract][Full Text] [Related]
16. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
Clark PE; Valentine V; Bodie JN; Sarwat S
Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
[TBL] [Abstract][Full Text] [Related]
17. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
[TBL] [Abstract][Full Text] [Related]
18. Gonadotrophin products: empowering patients to choose the product that meets their needs.
Weiss N
Reprod Biomed Online; 2007 Jul; 15(1):31-7. PubMed ID: 17623531
[TBL] [Abstract][Full Text] [Related]
19. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
Haak T; Edelman S; Walter C; Lecointre B; Spollett G
Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
Kivitz A; Cohen S; Dowd JE; Edwards W; Thakker S; Wellborne FR; Renz CL; Segurado OG
Clin Ther; 2006 Oct; 28(10):1619-29. PubMed ID: 17157117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
